0001558370-19-010609.txt : 20191108 0001558370-19-010609.hdr.sgml : 20191108 20191108161923 ACCESSION NUMBER: 0001558370-19-010609 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20191107 ITEM INFORMATION: Other Events FILED AS OF DATE: 20191108 DATE AS OF CHANGE: 20191108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MAGELLAN HEALTH INC CENTRAL INDEX KEY: 0000019411 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060] IRS NUMBER: 581076937 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-06639 FILM NUMBER: 191204313 BUSINESS ADDRESS: STREET 1: 4801 E. WASHINGTON ST CITY: PHOENIX STATE: AZ ZIP: 85034 BUSINESS PHONE: 800-642-1716 MAIL ADDRESS: STREET 1: 4801 E. WASHINGTON ST CITY: PHOENIX STATE: AZ ZIP: 85034 FORMER COMPANY: FORMER CONFORMED NAME: MAGELLAN HEALTH SERVICES INC DATE OF NAME CHANGE: 19960226 FORMER COMPANY: FORMER CONFORMED NAME: CHARTER MEDICAL CORP DATE OF NAME CHANGE: 19920703 8-K 1 mgln-20191107x8k185ba95.htm 8-K
MAGELLAN HEALTH INC0000019411false00000194112019-11-072019-11-07

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15 (D) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported):

November 7, 2019

MAGELLAN HEALTH, INC.

(Exact Name of Registrant as Specified in Charter)

​

​

​

Delaware

1-6639

58-1076937

(State or Other Jurisdiction

(Commission File

(IRS Employer

of Incorporation)

Number)

Identification No.)

​

​

​

4801 E. Washington Street

​

Phoenix, Arizona

85034

(Address of Principal Executive Offices)

(Zip Code)

​

Registrant’s telephone number, including area code: (800) 642-1716

​

(Former Name or Former Address, if Changed Since Last Report)

​

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

​

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.01 per share

MGLN

The NASDAQ Global Market

​

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

​

​

​

​

​

Item 8.01. Other Events

​

On November 7, 2019, Magellan Health Services, Inc. (the “Company”) was notified that the California Department of Health Services (“DHCS”) issued a Notice of Intent to Award a contract to the Company’s subsidiary, Magellan Medicaid Administration, Inc., for the provision of pharmacy benefit administration services statewide for a term of approximately five years. DHCS will also have five 1-year optional extension periods. The Company estimates annual revenue from the contract comprising administrative and service fees to be approximately $70 to $80 million. The contract go live date is planned to be January 1, 2021. The Notice of Intent to Award is subject to the negotiation of a definitive contract and the expiration of a protest period within which unsuccessful bidders have the right to protest the award. The deadline for filing protests is November 15, 2019. There is no assurance that protests will not be filed or that a definitive contract will be finalized.

​

​

​

​

​

​

​

​

2

​

​

​

​

SIGNATURES

​

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

​

MAGELLAN HEALTH, INC.

​

​

​

​

​

Date: November 8, 2019

By:

/s/ Jonathan N. Rubin

​

​

Name:   Jonathan N. Rubin

​

​

Title:     Chief Financial Officer

​

​

​

​

3

 EX-101.SCH 2 mgln-20191107.xsd EX-101.SCH 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 mgln-20191107_lab.xml EX-101.LAB EX-101.PRE 4 mgln-20191107_pre.xml EX-101.PRE XML 5 mgln-20191107x8k185ba95_htm.xml IDEA: XBRL DOCUMENT 0000019411 2019-11-07 2019-11-07 MAGELLAN HEALTH INC 0000019411 false 8-K 2019-11-07 DE 1-6639 58-1076937 4801 E. Washington Street Phoenix AZ 85034 800 642-1716 false false false false Common Stock, par value $0.01 per share MGLN NASDAQ false EXCEL 6 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 7 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3 html 1 97 1 false 0 0 false 0 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.magellanhealth.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports mgln-20191107x8k185ba95.htm mgln-20191107.xsd mgln-20191107_lab.xml mgln-20191107_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true false ZIP 10 0001558370-19-010609-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001558370-19-010609-xbrl.zip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end XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 R1.htm IDEA: XBRL DOCUMENT v3.19.3
Document and Entity Information
Nov. 07, 2019
Document and Entity Information [Abstract]  
Entity Central Index Key 0000019411
Document Type 8-K
Document Period End Date Nov. 07, 2019
Entity File Number 1-6639
Entity Registrant Name MAGELLAN HEALTH INC
Entity Incorporation, State or Country Code DE
Entity Tax Identificatoin Number 58-1076937
Entity Address, Address Line One 4801 E. Washington Street
Entity Address, City or Town Phoenix
Entity Address, State or Province AZ
Entity Address, Postal Zip Code 85034
City Area Code 800
Local Phone Number 642-1716
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.01 per share
Trading Symbol MGLN
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Amendment Flag false
JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "mgln-20191107x8k185ba95.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "mgln-20191107x8k185ba95.htm" ] }, "labelLink": { "local": [ "mgln-20191107_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "mgln-20191107_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "mgln-20191107.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 97, "memberCustom": 0, "memberStandard": 0, "nsprefix": "mgln", "nsuri": "http://www.magellanhealth.com/20191107", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "mgln-20191107x8k185ba95.htm", "contextRef": "Duration_11_7_2019_To_11_7_2019_Ya20j4GlKES18CyKy_xETw", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00090 - Document - Document and Entity Information", "role": "http://www.magellanhealth.com/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "mgln-20191107x8k185ba95.htm", "contextRef": "Duration_11_7_2019_To_11_7_2019_Ya20j4GlKES18CyKy_xETw", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.magellanhealth.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.magellanhealth.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.magellanhealth.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.magellanhealth.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.magellanhealth.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.magellanhealth.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.magellanhealth.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.magellanhealth.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.magellanhealth.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.magellanhealth.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.magellanhealth.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.magellanhealth.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.magellanhealth.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identificatoin Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.magellanhealth.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.magellanhealth.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.magellanhealth.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.magellanhealth.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.magellanhealth.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.magellanhealth.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.magellanhealth.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.magellanhealth.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.magellanhealth.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "mgln_DocumentAndEntityInformationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Document and Entity Information [Abstract]" } } }, "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://www.magellanhealth.com/20191107", "xbrltype": "stringItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } XML 14 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}